CENTELIMAB

Welcome to the Brand page for “CENTELIMAB”, which is offered here for Pharmaceutical preparations for use in the treatment of oncological diseases and disorders and complications associated therewith;.

Its status is currently believed to be active. Its class is unavailable. “CENTELIMAB” is believed to be currently owned by “IMMUNEX CORPORATION”.


Owner:
IMMUNEX CORPORATION
Owner Details
Description:
Pharmaceutical preparations for use in the treatment of oncological diseases and disorders and complications associated therewith;
Categories: PHARMACEUTICAL PREPARATIONS USE